IN SILICO STUDY OF ANTICANCER ACTIVITY OF PYRAZOLINE C AND M AS POTENTIAL SELECTIVE OF CYCLOOXYGENASE-2 (COX-2) INHIBITOR USING MOLECULAR DOCKING AND MD SIMULATIONS

DENNY SATRIA; SYUKUR BERKAT WARUWU; ETI NURWENING SHOLIKHAH; MUSTOFA; PAMUNGKAS  BAGUS SATRIYO; TUTIK DWI WAHYUNINGSIH; HESTI I. WIRASWATI; EMA  DAMAYANTI

doi:10.22159/ijap.2024v16s4.52247

Authors

DENNY SATRIA Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan-20155, Indonesia https://orcid.org/0000-0003-4724-3256
SYUKUR BERKAT WARUWU Faculty of Pharmacy and Health Sciences, Universitas Sari Mutiara Indonesia, Medan-20123, Indonesia
ETI NURWENING SHOLIKHAH Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta-55281, Indonesia
MUSTOFA Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta-55281, Indonesia
PAMUNGKAS BAGUS SATRIYO Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta-55281, Indonesia
TUTIK DWI WAHYUNINGSIH Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta-55281, Indonesia
HESTI I. WIRASWATI Parasitology Division, Department of Biomedical Science, Faculty of Medicine, Universitas Padjadjaran, Bandung-45363, Indonesia
EMA DAMAYANTI Research Center for Food Technology and Processing, National Research and Innovation, Agency, Gunungkidul-55861, Indonesia

DOI:

https://doi.org/10.22159/ijap.2024v16s4.52247

Keywords:

Pyrazolines C and M, COX-2, Anticancer drugs, Molecular docking, MD simulation

Abstract

Objective: This study has been carried out with an in silico approach to predict interactions between drug candidates and receptor COX-2 (5IKT) and analysed the Molecular Dynamic (MD) simulation.

Methods: The docking procedure was executed with the MolDock algorithm, which was incorporated into Molegro Virtual Docker 5.0, employing the specific docking strategy. MD simulation was analysed with GROMACS 2019 for a duration of 50 nanoseconds. A graph is used to illustrate the interpretation of MD, depicting the Root mean Square Deviation (RMSD) on the backbone, the RMSF on C-alpha, and the Solvent-Accessible Surface Area (SASA) on the protein. This is accomplished via the qtGrace program.

Results: Pyrazoline C and M were used as ligands and celecoxib as a commercial drug. Pyrazoline M was the ligand with the highest affinity (-103.463 Kcal/mol) if compared with Pyrazoline C (-100.900 Kcal/mol), native ligand tolfenamic acid (-87.588 Kcal/mol) and celecoxib (-95.832 Kcal/mol). The molecular dynamics simulation for 50 ns was showed that RMSD, RMSF and SASA rigid and stable.

Conclusion: Pyrazoline C and M was the potential to develop as a breast cancer drug with COX-2 inhibitory activity.

Downloads

Download data is not yet available.

References

Satria D, Silalahi J, Haro G, Ilyas S, Zaitun Hasibuan PA. Chemical analysis and cytotoxic activity of nhexane fraction of Zanthoxylum acanthopodium DC. fruits. Rasayan J Chem. 2019;12(2):803-8. doi: 10.31788/RJC.2019.1225180.

Waskitha SS, Wahyuningsih TD, Sholikhah EN. Potent A EGFR inhibitor, N-phenyl pyrazoline derivative suppresses aggressiveness and cancer stem cell-like phenotype of cervical cancer cells. Drug Des Dev Ther. 2022;20(16):2325-39. doi: 10.2147/DDDT.S350913.

Chaudhary M, Kumar N, Baldi A, Chandra R, Babu MA, Madan J. 4-Bromo-4’-Chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: in silico-guided analysis, synthesis, and in vitro cytotoxicity. J Biomol Struct Dyn. 2020;38(5):1335-53. doi: 10.1080/07391102.2019.1604266, PMID 30957694.

Kumari P, Vishnu S, Mishra, Chintam N, Ashish K, Anindita C, Ram S. Design and efficient synthesis of pyrazoline and isoxazole bridged indole c-glycoside hybrids as potential anticancer agents. Scientific Reports. 2020;10(1). doi: 10.1038/s41598-02063377-x.

Wang H, Zheng J, Xu W, Chen C, Wei D, Ni W. A new series of cytotoxic pyrazoline derivatives as potential anticancer agents that induce cell cycle arrest and apoptosis. Molecules. 2017;22(10). doi: 10.3390/molecules22101635, PMID 28961210.

Yusuf M, Jain P. Synthetic and biological studies of pyrazolines and related heterocyclic compounds. Arab J Chem. 2014;7(5):553-96. doi: 10.1016/j.arabjc.2011.09.013.

Suma AA, Wahyuningsih TD, Pranowo D. Synthesis and antibacterial activities of n-phenyl pyrazolines from veratraldehyde. Mater Sci Forum. 2017;901:124-32. doi: 10.4028/www.scientific.net/MSF.901.124.

Wahyuningsih TD, Suma AA, Astuti E. Synthesis, anticancer activity, and docking study of N-acetyl pyrazolines from veratraldehyde. J App Pharm Sci. 2019;9(3):14-20. doi: 10.7324/JAPS.2019.90303.

Rana M, Arif R, Khan FI, Maurya V, Singh R, Faizan MI. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies. Bioorg Chem. 2021;108:104665. doi: 10.1016/j.bioorg.2021.104665, PMID 33571809.

Syahputra RA, Harahap U, Dalimunthe A, Nasution P, Haro G, Widodo. In-silico toxicity prediction of bioactive compounds of vernonia amygdalina delile and digoxin. Rasayan J Chem. 2020;13(2):1220-4. doi: 10.31788/RJC.2020.1325638.

Satria D, Waruwu SB, Sholikhah EN, Mustofa S, Satriyo PB, Wahyuningsih TD. In silico analysis of n-phenyl pyrazoline derivates as potential of human epidermal growth receptor-2 (her-2) inhibitor using molecular docking and md simulations. RJC. 2024;17(2):356-62. doi: 10.31788/RJC.2024.1728795.

Orlando BJ, Malkowski MG. Substrate-selective inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. J Biol Chem. 2016;291(29):15069-81. doi: 10.1074/jbc.M116.725713. PMID 27226593.

Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006;49(11):3315-21. doi: 10.1021/jm051197e, PMID 16722650.

Abraham MJ, Murtola T, Schulz R, Pall S, Smith JC, Hess B. Gromacs: high-performance molecular simulations through multi-level parallelism from laptops to supercomputers. Software X. 2015;1-2:19-25. doi: 10.1016/j.softx.2015.06.001.

Lindorff Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO. Improved side-chain torsion potentials for the amber Ff99SB protein force field. Proteins. 2010;78(8):1950-8. doi: 10.1002/prot.22711, PMID 20408171.

Mhatre S, Patravale V. Drug repurposing of triazoles against mucormycosis using molecular docking: a short communication. Comput Biol Med. 2021;136:104722. doi: 10.1016/j.compbiomed.2021.104722, PMID 34358995.

Warude BJ, Wagh SN, Chatpalliwar VA, Yildirim M, Celik I, Rudrapal M. Design, docking, MD simulation and in-silco ADMET prediction studies of novel indole-based benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy. Pharmacia. 2023;70(2):307-16. doi: 10.3897/pharmacia.70.e100356.

Trott O, Olson AJ. Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61. doi: 10.1002/jcc.21334, PMID 19499576.

Hasibuan PA, Harahap U, Sitorus P, Lubis MF, Satria D. In silico analysis of vernonioside d and vernonioside e from vernonia amygdalina delile. leaves as an inhibitor of epidermal growth factor receptor (egfr) and mammalian target of rapamycin (mTOR). Rasayan J Chem. 2021;14(3):1539-43. doi: 10.31788/RJC.2021.1436092.

Huang Y, Zhang X, Suo H. Interaction between β-lactoglobulin and EGCG under high-pressure by molecular dynamics simulation. PLOS ONE. 2021;16(12):e0255866. doi: 10.1371/journal.pone.0255866, PMID 34932559.

Krebs B. Baumgarten, and Joelma freire de Mesquita. “Amyotrophic lateral sclerosis type 20-in silico analysis and molecular dynamics simulation of HnRNPA1. Plos One. 2016;11(7):1-18. doi: 10.1371/journal.pone.0158939.